Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(0)
•••
Comment by wesdevrieson May 30, 2014 2:42pm
192 Views
Post# 22615982

RE:RE:RE:bbb

RE:RE:RE:bbbWhich one of "dumb and dumber" are you oil? Before you get ahead of yourself their "packer boy"; I was reading your post from a while ago on how smart you consider yourself and how much money you make! Let me clarify for the board; I could teach my kids in about an hour what you know and what you do; you're the typical oilpatch "know-it-all" that knows nothing...in other words, you couldn't drill yourself out of a wet paper bag! You're not in control of anything other than "simplistic" repetitious labor" and maybe get to drop balls...there's no thinking on your part and that's why you do the job that you do! All "big mouths" like you in the oil patch do these types of jobs! And where's that buddy of yours "observer"; which one of "dumb and dumber" is he? 

Isn't it time to shut-up and then grow-up there "slick"...how old are you?? And if you have something to say to me...say it...without hiding behind a bullboard alias!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities